Synthetic generation replicates key clinical patterns from real-world data, enabling valid analyses with fewer patients.

Several oncology companies announced key trial milestones this week across the landscape of both blood cancers and solid ...

Amgen Inc (($AMGN)) announced an update on their ongoing clinical study. Amgen Inc., in collaboration with Asher ...

ALEX TORDOFF is relishing the prospect of fulfilling a lifelong dream as he saddles up for his Defender Burghley Horse Trials debut.

HBAR tests key support at $0.23 after a 3% pullback Friday, with resistance forming near $0.24. Bullish catalysts emerge as ...

The upcoming Clinical Trials in Rare Diseases conference will cover the most concerning challenges in rare disease research.

In this episode presented by Cresset, BioSpace’s head of insights Lori Ellis discusses clinical trial fail rates and AI’s ...

Kimberly (Cary) Demirhan, a registered nurse and assistant director of Education Programs at the Association of Cancer Care Centers (ACCC), sat down for an interview with CURE to discuss the need for ...

The company plans to continue with a lower dose and a change in the pre-treatment regimen after a trial participant died ...

In a Phase 3 trial, drugmaker Eli Lilly and Company said it's oral GLP-1 pill showed similar results to injectable weight loss options after a 72-week period.

Eli Lilly is one step closer to bringing an oral weight loss medicine to the booming obesity drug market. A clinical trial saw people lose 12% of body weight.

Michela Cimberle, senior staff writer for Healio | OSN, won an APEX Award of Excellence for a 2024 exclusive story on diversity in clinical trials and efforts to improve health equality. Cimberle ...